Literature DB >> 12567398

Endometrial arteriogenesis: vascular smooth muscle cell proliferation and differentiation during the menstrual cycle and changes associated with endometrial bleeding disorders.

Peter A W Rogers1, Keren M Abberton.   

Abstract

The cyclical regrowth of the human endometrial vasculature every 28 days following menstruation provides an excellent opportunity for studying arteriogenesis in a human tissue. Despite this, very little has been published to date about temporal or spatial changes in endometrial arteriolar structure or function. Immunohistochemical studies using vascular smooth muscle cell (VSMC) differentiation markers have identified spatially organised differences in VSMC phenotype. However, these have not significantly increased our understanding of how or when arteriogenesis occurs. Endometrial VSMC proliferation continues at a steady rate throughout the cycle, increasing in the specialised spiral arterioles in the mid and late secretory phases. Although estrogen and progesterone play a dominant role in regulating endometrial growth and regression, their direct involvement in arteriogenesis is less clear. Estrogen and progesterone receptors have been reported in endometrial VSMC, although heterogeneity of expression occurs. The angiopoietin/Tie axis has been investigated in endometrium, although the results of 3 studies published to date are contradictory, making conclusions about a role in arteriogenesis problematic. Abnormalities of arteriogenesis may play a role in disorders such as menorrhagia and breakthrough bleeding in contraceptive and hormone replacement therapy users. There is evidence that VSMC proliferation is reduced in spiral arterioles of women with menorrhagia, along with reduced pulsatility index of the uterine artery as shown by Doppler ultrasound. In women taking progestin-only contraception, endometrial perivascular alpha smooth muscle actin is reduced in those who suffer from breakthrough bleeding compared to those that don't. Considerable work is still required to elucidate when in the cycle, where in the tissue, and what mechanisms regulate endometrial arteriogenesis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12567398     DOI: 10.1002/jemt.10279

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  7 in total

Review 1.  Trophoblast-mediated spiral artery remodelling: a role for apoptosis.

Authors:  Guy St J Whitley; Judith E Cartwright
Journal:  J Anat       Date:  2009-02-09       Impact factor: 2.610

Review 2.  The endometrial lymphatic vasculature: function and dysfunction.

Authors:  Jane E Girling; Peter A W Rogers
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

Review 3.  Killer Timing: The Temporal Uterine Natural Killer Cell Differentiation Pathway and Implications for Female Reproductive Health.

Authors:  Rupsha Fraser; Ana Claudia Zenclussen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-27       Impact factor: 6.055

4.  Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception.

Authors:  Graciela Krikun; Denny Sakkas; Frederick Schatz; Lynn Buchwalder; Donna Hylton; Caroline Tang; Charles J Lockwood
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

5.  Genipin inhibits TNF-α-induced vascular smooth muscle cell proliferation and migration via induction of HO-1.

Authors:  Fengrong Jiang; Rilei Jiang; Xiaojia Zhu; Xu Zhang; Zhan Zhan
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

Review 6.  Molecular and functional aspects of menstruation in the macaque.

Authors:  Robert M Brenner; Ov D Slayden
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

7.  Endothelial-Specific EphA4 Negatively Regulates Native Pial Collateral Formation and Re-Perfusion following Hindlimb Ischemia.

Authors:  Benjamin Okyere; Kaavya Giridhar; Amanda Hazy; Miao Chen; David Keimig; Robert C Bielitz; Hehuang Xie; Jia-Qiang He; William R Huckle; Michelle H Theus
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.